1. Home
  2. MESO vs JBLU Comparison

MESO vs JBLU Comparison

Compare MESO & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$14.52

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$4.25

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESO
JBLU
Founded
2004
1998
Country
Australia
United States
Employees
108
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2005
2002

Fundamental Metrics

Financial Performance
Metric
MESO
JBLU
Price
$14.52
$4.25
Analyst Decision
Strong Buy
Sell
Analyst Count
1
13
Target Price
N/A
★ $4.91
AVG Volume (30 Days)
157.0K
★ 16.6M
Earning Date
02-26-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 27.83
EPS
★ N/A
N/A
Revenue
N/A
★ $9,062,000,000.00
Revenue This Year
$629.74
$12.11
Revenue Next Year
$30.65
$6.75
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$13.05
$3.87
52 Week High
$21.50
$6.62

Technical Indicators

Market Signals
Indicator
MESO
JBLU
Relative Strength Index (RSI) 39.88 36.58
Support Level $14.18 $3.87
Resistance Level $16.06 $5.27
Average True Range (ATR) 0.42 0.16
MACD -0.08 0.03
Stochastic Oscillator 13.93 9.09

Price Performance

Historical Comparison
MESO
JBLU

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

Share on Social Networks: